Current role
Christopher J. Scoggins
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher J. Scoggins
The proxy statement of Abbott Laboratories reports total compensation of $6,601,667 for Christopher J. Scoggins in fiscal 2025, including a base salary of $859,502.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Abbott Laboratories (ABT)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Abbott Laboratories
Other people whose current roles at this company are on record from its filings.
- Robert B. Ford CEO, Chairman, Board Member
- Philip P. Boudreau CFO
- Robert E. Funck, Jr. CFO
- Hubert L. Allen General Counsel
- Claire Babineaux-Fontenot Board Member
- Daniel J. Starks Board Member
- Darren W. McDew Board Member
- John G. Stratton Board Member
- Kevin Conroy Board Member
- Michael F. Roman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Abbott Laboratories (ABT) | Executive Vice President, Diabetes Care | $859,502 | $6,601,667 |
Recent activity
No call appearances or filed executive changes recorded yet.